PharmaCielo Ltd (PCLOF)
0.1408
-0.03
(-16.43%)
USD |
OTCM |
May 31, 16:00
PharmaCielo Gross Profit Margin (Quarterly): -99.29% for Sept. 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -99.29% |
| June 30, 2023 | -381.9% |
| March 31, 2023 | -24.60% |
| December 31, 2022 | 12.89% |
| September 30, 2022 | -64.35% |
| June 30, 2022 | 39.40% |
| March 31, 2022 | 8.58% |
| December 31, 2021 | -164.1% |
| Date | Value |
|---|---|
| September 30, 2021 | -278.2% |
| June 30, 2021 | -181.1% |
| March 31, 2021 | -126.7% |
| December 31, 2020 | -257.3% |
| September 30, 2020 | -16.84K% |
| June 30, 2020 | 12.37% |
| March 31, 2020 | -30.47% |
| December 31, 2019 | -577.5% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-16.84K%
Minimum
Sep 2020
39.40%
Maximum
Jun 2022
-1.18K%
Average
-113.0%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | 24.69% |
| Venus Concept Inc | 66.63% |
| Juva Life Inc | 21.44% |
| Lucy Scientific Discovery Inc | 60.06% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -245.0% |
| Return on Assets | -49.42% |
| Return on Invested Capital | -67.08% |
| Profit Margin (Quarterly) | -784.9% |
| Operating Margin (Quarterly) | -663.0% |
| Return on Net Operating Assets | -50.54% |